Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ABATACEPT
- Non-myeloablative Haploidentical HCT Study for Patients With Sickle Cell Disease, Including Compromised Organ Function
- Comparative Pharmacokinetic Study of Three Abatacept Products in Male Normal Healthy Volunteers by the Subcutaneous Route
- Subcutaneous Abatacept in Renal Transplant Recipients
- Strategies and Treatments for Respiratory Infections &Amp; Viral Emergencies (STRIVE): Immune Modulation Strategy Trial
- Insulin and Abatacept in Recently-diagnosed Type 1 Diabetes
- The Effect of Cilostazol on Rheumatoid Arthritis Patients
- Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHD
- Pharmacokinetic Infliximab Data in Pediatric Crohn's Disease
- Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis
- Efficacy of a Sequential Treatment Strategy in Rheumatoid Arthritis
- Thal-Fabs: Reduced Toxicity Conditioning for High Risk Thalassemia
- Abatacept in Immune Checkpoint Inhibitor Myocarditis
- A Study to Evaluate Efficacy and Safety of Abatacept in Participants of Pemphigus Vulgaris (PV)
- A Phase I-II Study of High-Dose Post-Transplant Cyclophosphamide, Bortezomib and Abatacept for the Prevention of Graft-versus-Host-Disease (GvHD) Following Allogenic Hematopoietic Stem Cell Transplantation (HSCT)
- AbataCept for the Treatment of Immune-cHeckpoint Inhibitors Induced mYocarditiS
- COVID-19 VaccinE Response in Rheumatology Patients
- Abatacept Conversion in Kidney Transplantation
- An Exploratory Study on the Efficacy and Safety of Abatacept in the Treatment of Refractory Dermatomyositis
- Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
- A Study to Compare the Response to Treatment With Abatacept vs Adalimumab, on Background Methotrexate, in Adults With Early, Seropositive, and Shared Epitope-positive Rheumatoid Arthritis and an Inadequate Response to Methotrexate
- Adjuvant Treatment With Abatacept to Promote Remission During Peanut Oral Immunotherapy
- Study of Salvage Therapy to Treat Patients With Granulomatosis With Polyangiitis
- Combination of Baricitinib and Adalimumab in Rheumatoid Arthritis
- Abatacept s.c. for aGVHD Prevention in Haplo-HCT
- Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis
- Immune Modulators for Treating COVID-19
- Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention
- Abatacept for Patients With COVID-19 and Respiratory Distress
- Abatacept for the Treatment of Giant Cell Arteritis
- Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis
- Impact of T Cells on Age-related Vascular Dysfunction: A Translational Approach
- Abatacept in Individuals Who aRe Considered At Risk of Developing Inflammatory Arthritis
- Biologics for Rheumatoid Arthritis Pain (BIORA-PAIN)
- Abatacept for Treatment of Recurrent or de Novo Autoimmune Hepatitis
- Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants
- TOLERA: Tolerance Enhancement in RA
- Early Markers of Disease and Response to Therapy
- Abatacept Bone Effects in Psoriatic Arthritis With Bone Biomarker
- Rituximab and Abatacept for Prevention or Reversal of Type 1 Diabetes
- Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant Transplant
- A Study to Evaluate Biomarkers to Predict Efficacy of Abatacept in Rheumatoid Arthritis
- Abatacept in Patients With Birdshot HLA A29 Uveitis
- Preventing Extension of Oligoarticular Juvenile Idiopathic Arthritis JIA (Limit-JIA)
- Usefulness of Non TNF Usage in RA Patients
- PRI-VENT FSGS: Preemptive Rituximab to Prevent Recurrent Focal Segmental Glomerulosclerosis Post-Transplant
- A Study Comparing Biologics + Methotrexate With Biologics + Tacrolimus in Patients With Rheumatoid Arthritis (RA)
- Safety and Efficacy of Abatacept for Treating Chronic Cytopenia in Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) Haploinsufficiency
- A Study to Evaluate the Pharmacokinetics of Abatacept Converted From Drug Substance by Two Different Processes
- Ustekinumab for the Treatment of Relapse of Refractory Giant Cell Arteritis
- Rheumatoid Arthritis Memory B Cells and Abatacept (RAMBA)
- Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation in Patients With Hematologic Malignancy
- Safety and Efficacy of Abatacept in IgG4-Related Disease
- EFFECTS OF ABATACEPT on the Progression to Rheumatoid Arthritis(PALABA Study)
- Rheumatoid Arthritis Memory B Cells and Abatacept (RAMBA)
- Abatacept in earLy Onset Polymyalgia Rheumatica: Study ALORS
- Effects of Abatacept on Myocarditis in Rheumatoid Arthritis
- Human Umbilical Cord Mesenchymal Stem Cells Treatment for Lupus Nephritis (LN)
- Comparative Clinical Efficacy and Safety of Coded Polyherbal Medicine for the Management of Arthritis
- Abatacept to Silence Anti-citrullinated Protein Antibody-expressing B Cells in Rheumatoid Arthritis (ASCARA)
- Abatacept, Ixazomib Citrate, and Dexamethasone in Treating Patients With Multiple Myeloma Resistant to Chemotherapy
- Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
- Abatacept vs Tocilizumab for the Treatment of RA in TNF Alpha Inhibitor Inadequate Responders
- Abatacept for the Treatment of Myositis-associated Interstitial Lung Disease
- A Study to Evaluate Efficacy and Safety of Subcutaneous Abatacept With Steroid Treatment Compared to Steroid Treatment Alone in Adults With Giant Cell Arteritis (GCA)
- A Phase 3 Study to Compare Upadacitinib to Abatacept in Subjects With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease- Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response or Intolerance to Biologic DMARDs
- APRIL (AbatacePt in Rheumatoid Arthritis-ILD)
- Trial of Orencia in Patients With Myasthenia Gravis
- Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy
- Abatacept for GVHD Prophylaxis After Hematopoietic Stem Cell Transplantation for Pediatric Sickle Cell Disease
- Treatment Tapering in JIA With Inactive Disease
- Pharmacokinetics, Safety and Tolerability Study of Single Dose of Abatacept 125mg Administered Subcutaneously
- Abatacept Reversing Subclinical Inflammation as Measured by MRI in ACPA Positive Arthralgia
- A Phase 3 Study of Abatacept in Chinese Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate
- Clinical Trial Evaluating Methotrexate + Biologic Versus Methotrexate, Salazopyrine and Hydroxychloroquine in Patients With Rheumatoid Arthritis and Insufficient Response to Methotrexate
- Inhibition of Co-Stimulation in Rheumatoid Arthritis
- Patient-Reported Efficacy of Subcutaneous (SC) Abatacept in Rheumatoid Arthritis (RA) - South Africa
- Abatacept in Juvenile Dermatomyositis
- Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)
- Study to Assess Changes in the Immune Profile in Adults With Early Rheumatoid Arthritis
- Vaccination Against Pneumococcal in Naïve Abatacept Rheumatoid Arthritis Patients
- Effects of Abatacept in Patients With Early Rheumatoid Arthritis
- Dose Reduction for Early Rheumatoid Arthritis Patients With Low Disease Activity
- Abatacept for SLE Arthritis (IM101-330)
- Mechanistic Studies of B- and T-Cell Function in RA Patients Treated With TNF Antagonists, Tocilizumab, or Abatacept
- Open-label Pilot Study of Abatacept for the Treatment of Vitiligo
- Treatment of Resistant Hypertension by Prevention of T-Cell Co-Stimulation
- Post-marketing Study Assessing the Long-Term Safety of Abatacept
- A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis
- Long Term Experience With Abatacept in Routine Clinical Practice
- Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)
- Long-term Experience With Abatacept SC in Routine Clinical Practice
- Efficacy and Safety of Abatacept in Patients With Primary Sjögren's Syndrome
- Abatacept vs Placebo in RA Patients With Hepatitis B on Entecavir Background
- Impact and Use of Abatacept IV for Rheumatoid Arthritis in Real Life Setting
- Abatacept for Patients With Inflammatory Arthritis Associated With Sjögren's Syndrome: an Open-Label Phase II Study
- An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata
- Efficacy of Ustekinumab Followed by Abatacept for the Treatment of Psoriasis Vulgaris
- A Phase I Study of Abatacept in the Treatment of Patients With Steroid Refractory Chronic Graft Versus Host Disease (cGVHD)
- Bone Marrow Transplant With Abatacept for Non-Malignant Diseases
- A Clinical Trial to Evaluate the Efficacy of Abatacept in Moderate to Severe Alopecia Areata
- Study to Characterize the Pharmacokinetics of a Single Dose of SC Abatacept 125 mg Using the BD Autoinjector or the Prefilled Syringe
- Efficacy and Safety of Subcutaneous Abatacept in Adults With Active Psoriatic Arthritis
- Introducing a Single IV Abatacept Treatment in RA Patients Currently Receiving Weekly SC Abatacept to Simulate a Holiday
- Methotrexate-Inadequate Response Autoinjector Device Sub Study
- Efficacy, Safety, Pharmacokinetics and Immunogenicity Study of Abatacept Administered Intravenously to Treat Active Polyarticular-course Juvenile Idiopathic Arthritis in Japan
- CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1
- Abatacept Post-marketing Clinical Study in Japan
- Abatacept as GVHD Prophylaxis Phase 2
- Effect on Orencia (Abatacept) on the Apoptosis of T Cells, B Cells and APC Cells in Rheumatoid Arthritis
- Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis
- A Pilot Study of the Safety and Efficacy of Abatacept Injections in the Treatment of Behcet's Syndrome
- A Randomized, Multi-Center Biomarker Trial to Predict Therapeutic Responses of Patients With Rheumatoid Arthritis to a Specific Biologic Mode of Action
- Korean Post-marketing Surveillance for Orencia®
- TOward the Lowest Effective DOse of Abatacept or Tocilizumab
- Real-world Clinical Efficacy of Abatacept in the T3 Data Registry
- Active Conventional Therapy Compared to Three Different Biologic Treatments in Early Rheumatoid Arthritis With Subsequent Dose Reduction
- A Study to Assess the Receptor Occupancy of CD86 and CD80 in Subjects With Rheumatoid Arthritis Initiating Abatacept
- Abatacept Treatment in Polymyositis and Dermatomyositis
- Abatacept Costimulatory Blockade in the Treatment of Alopecia Totalis/Universalis
- Ultrasound Scores as Indication of Response to Subcutaneous Abatacept in Subjects With Rheumatoid Arthritis
- SWITCH Clinical Trial for Patients With Rheumatoid Arthritis Who Have Failed an Initial TNF-blocking Drug.
- Abatacept in the Treatment of Uveitis
- Study on the Safety of Abatacept in Relapsing Polychondritis
- Pharmacokinetic Study to Compare the Blood Levels of Low vs High Metal Manufacture of Abatacept
- Efficacy and Safety Study of Abatacept Subcutaneous Plus Methotrexate in Inducing Remission in Adults With Very Early Rheumatoid Arthritis
- A Cooperative Clinical Study of Abatacept in Multiple Sclerosis
- Abatacept Pregnancy Exposure Registry
- Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT
- Efficacy, Pharmacokinetics, Safety, and Immunogenicity Study of Abatacept Administered Subcutaneously to Treat Rheumatoid Arthritis in Japanese Patients
- Rotation or Change of Biotherapy After First Anti-TNF Treatment Failure for Rheumatoid Arthritis
- Substudy - Low Dose of Abatacept in Subjects With Rheumatoid Arthritis
- Abatacept Versus Adalimumab Head-to-Head
- Safety and Efficacy of Abatacept in Subjects With Chronic Urticaria Who Have Had an Inadequate Response to Anti-histamine Therapy
- The Effect of Inhibition of B7-mediated Costimulation on Allergic Airway Inflammation in Mild Atopic Asthmatics
- Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
- A Rheumatoid Arthritis Study to Assess Early Response to Abatacept+MTX as Defined by Improvement of Synovitis Measures by Power Doppler Ultrasonography
- Safety Study of Abatacept to Treat Refractory Sarcoidosis
- Phase I Study in China - Tolerability of a Single Dose of Abatacept 30 mg/kg
- Phase IIIB Switching From Intravenous to Subcutaneous Study
- Methotrexate-Inadequate Response Study
- Pilot Open Label Clinical Trial With Abatacept in Ankylosing Spondylitis
- Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis
- Phase IIIB Subcutaneous Abatacept Monotherapy Study
- Safety and Efficacy of Abatacept Versus Placebo in Participants With Psoriatic Arthritis
- Phase IIIB Subcutaneous Missed Dose Study
- Intravenous CTLA4-lg Treatment in Recent Onset Type 1 Diabetes Mellitus
- A Phase III Study of Abatacept in Japanese Subjects With Rheumatoid Arthritis
- Abatacept in ANCA Associated Vasculitis
- Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis
- A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma)
- Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis
- A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate
- A Study of Abatacept in Patients With Active Ulcerative Colitis
- A Phase III Study of Abatacept in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate
- A Study of Abatacept in Patients With Active Crohn's Disease
- Evaluation of 2 Oral Doses of PG-760564 in Rheumatoid Arthritis (RA) Patients Receiving Methotrexate
- A Study of Abatacept in Japanese Patients With Active Rheumatoid Arthritis While Receiving Methotrexate
- Phase I Study of BMS-188667 (CTLA4Ig) in Patients With Psoriasis Vulgaris
- Phase I/II Multiple-Dose LEA29Y vs CTLAG4Ig vs Placebo in Rheumatoid Arthritis
- Vaccination Study of Abatacept (BMS-188667) for Normal Healthy Volunteers
- A Study to Assess the Pharmacokinetics, Immunogenicity and Safety of Escalating Doses of BMS-188667 Given as a Single Intravenous Infusion to Patients With Psoriasis Vulgaris
- Comparability DE vs CD-CHO1
- Islet Transplantation Using Abatacept
- Study to Assess Steady-State Trough Concentrations, Safety, and Immunogenicity of Abatacept After Subcutaneous (SC) Administration to Subjects With Rheumatoid Arthritis (RA)
- The Study of Abatacept in Combination With Etanercept
- Abatacept With Methotrexate- Phase IIB
- An Exploratory Study of Changes in Synovial Immune Responses Following BMS-188667 Therapy in Subjects With Active Rheumatoid Arthritis on Background DMARDs Who Have Failed Anti-TNF Therapy
- Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy
- Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult Patients
- Remission and Joint Damage Progression in Early Rheumatoid Arthritis
- Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus (SLE) Flares in Combination With Prednisone
- BMS-188667 in Children and Adolescents With Juvenile Rheumatoid Arthritis
- Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid Arthritis
- A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis
- Phase III Study of BMS-188667 (CTLA4Ig) in Patients With Rheumatoid Arthritis Who Are Currently Failing Anti-TNF Therapy or Who Have Failed Anti-TNF Therapy in the Past.
- A Phase III Study of Abatacept (BMS-188667) in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate
Clinical trials list
click for details